Migraine improvement during short lasting ketogenesis: a proof-of-concept study

被引:98
作者
Di Lorenzo, C. [1 ]
Coppola, G. [2 ]
Sirianni, G. [3 ]
Di Lorenzo, G. [4 ]
Bracaglia, M. [5 ]
Di Lenola, D. [5 ]
Siracusano, A. [4 ]
Rossi, P. [6 ,7 ]
Pierelli, F. [8 ]
机构
[1] Don Carlo Gnocchi Onlus Fdn, Milan, Italy
[2] GB Bietti Fdn IRCCS, Dept Neurophysiol Vis & Neurophthalmol, Rome, Italy
[3] Krom Genet Inst, Rome, Italy
[4] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy
[5] Univ Roma La Sapienza, Dept Medsurg Sci & Biotechnol, Latina, Italy
[6] INI, Headache Clin, Grottaferrata, RM, Italy
[7] Univ Consortium Adapt Disorders & Head Pain UCADH, Pavia, Italy
[8] IRCCS Neuromed, Pozzilli, IS, Italy
关键词
ketogenesis; ketogenic diet; ketone bodies; migraine; very-low-calorie diet; ANTICONVULSANT MECHANISM; ALTERNATIVE MEDICINE; CLUSTER HEADACHE; DIET; KETOSIS; COMPLEMENTARY; PROPHYLAXIS; ADOLESCENTS; RIBOFLAVIN; GLUTAMATE;
D O I
10.1111/ene.12550
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: Ketogenesis is a physiological phenomenon due to starvation or a ketogenic diet (KD), a drastic restricted carbohydrate dietary regimen that induces lipid metabolism and ketone body synthesis. Two patients whose migraines disappeared only during, and not outside, cycles of very-low-calorie KD performed to reduce their weight were recently observed. To confirm our observation, in a dietitian clinical setting two parallel groups of migraineurs, one receiving a 1-month very-low-calorie KD prescription followed by a 5-month standard low-calorie diet (SD) and the other a 6-month SD, were followed. Methods: Ninety-six overweight female migraineurs were enrolled in a diet clinic and blindly received a KD (n = 45) or an SD (n = 51) prescription. Mean monthly attack frequency, number of days with headaches and tablet intake were assessed before and 1, 2, 3 and 6 months after diet initiation. Results: In the KD group, the baseline attack frequency (2.9 attacks per month), number of days with headaches (5.11 days per month) and tablet intake (4.91 doses per month) were significantly reduced after the first month of diet (respectively 0.71, 0.91, 0.51; overall, KD versus baseline, P < 0.0001). During the transition period (first versus second month), the KD group showed a transient worsening of each clinical headache variable (respectively 2.60, 3.60, 3.07), despite being improved compared with baseline, with continuous improvement up to month 6 (respectively 2.16, 2.78, 3.71). In the SD group, significant decreases in the number of days with headaches and tablet intake were observed only from month 3 (P < 0.0001), and in attack frequency at month 6 (P < 0.0001). Conclusions: The underlying mechanisms of KD efficacy could be related to its ability to enhance mitochondrial energy metabolism and counteract neural inflammation.
引用
收藏
页码:170 / 177
页数:8
相关论文
共 34 条
[1]   The International Classification of Headache Disorders, 3rd edition (beta version) [J].
Bes, Andre ;
Kunkel, Robert ;
Lance, James W. ;
Nappi, Giuseppe ;
Pfaffenrath, Volker ;
Rose, Frank Clifford ;
Schoenberg, Bruce S. ;
Soyka, Dieter ;
Tfelt-Hansen, Peer ;
Welch, K. Michael A. ;
Wilkinson, Marica ;
Olesen, Jes ;
Bousser, Marie-Germaine ;
Diener, Hans-Christoph ;
Dodick, David ;
First, Michael ;
Goadsby, Peter J. ;
Goebel, Hartmut ;
Lainez, Miguel J. A. ;
Lance, James W. ;
Lipton, Richard B. ;
Nappi, Giuseppe ;
Sakai, Fumihiko ;
Schoenen, Jean ;
Silberstein, Stephen D. ;
Steiner, Timothy J. ;
Olesen, Jes ;
Bendtsen, Lars ;
Dodick, David ;
Ducros, Anne ;
Evers, Stefan ;
First, Michael ;
Goadsby, Peter J. ;
Hershey, Andrew ;
Katsarava, Zaza ;
Levin, Morris ;
Pascual, Julio ;
Russell, Michael B. ;
Schwedt, Todd ;
Steiner, Timothy J. ;
Tassorelli, Cristina ;
Terwindt, Gisela M. ;
Vincent, Maurice ;
Wang, Shuu-Jiun ;
Olesen, J. ;
Evers, S. ;
Charles, A. ;
Hershey, A. ;
Lipton, R. ;
First, M. .
CEPHALALGIA, 2013, 33 (09) :629-808
[2]   Obesity, migraine, and chronic migraine - Possible mechanisms of interaction [J].
Bigal, Marcelo E. ;
Lipton, Richard B. ;
Holland, Philip R. ;
Goadsby, Peter J. .
NEUROLOGY, 2007, 68 (21) :1851-1861
[3]   Obesity is a risk factor for transformed migraine but not chronic tension-type headache [J].
Bigal, Marcelo E. ;
Lipton, Richard B. .
NEUROLOGY, 2006, 67 (02) :252-257
[4]   Improvement of migraine headaches in severely obese patients after bariatric surgery [J].
Bond, D. S. ;
Vithiananthan, S. ;
Nash, J. M. ;
Thomas, J. G. ;
Wing, R. R. .
NEUROLOGY, 2011, 76 (13) :1135-1138
[5]   Energy metabolism as part of the anticonvulsant mechanism of the ketogenic diet [J].
Bough, Kristopher .
EPILEPSIA, 2008, 49 :91-93
[6]   Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet [J].
Bough, Kristopher J. ;
Wetherington, Jonathon ;
Hassel, Bjornar ;
Pare, Jean Francois ;
Gawryluk, Jeremy W. ;
Greene, James G. ;
Shaw, Renee ;
Smith, Yoland ;
Geiger, Jonathan D. ;
Dingledine, Raymond J. .
ANNALS OF NEUROLOGY, 2006, 60 (02) :223-235
[7]   Habituation and sensitization in primary headaches [J].
Coppola, Gianluca ;
Di Lorenzo, Cherubino ;
Schoenen, Jean ;
Pierelli, Francesco .
JOURNAL OF HEADACHE AND PAIN, 2013, 14
[8]   Abnormal cortical responses to somatosensory stimulation in medication-overuse headache [J].
Coppola, Gianluca ;
Curra, Antonio ;
Di Lorenzo, Cherubino ;
Parisi, Vincenzo ;
Gorini, Manuela ;
Sava, Simona Liliana ;
Schoenen, Jean ;
Pierelli, Francesco .
BMC NEUROLOGY, 2010, 10
[9]   The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders [J].
Cullingford, TE .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2004, 70 (03) :253-264
[10]   The ketogenic diet upregulates expression of the gene encoding the key ketogenic enzyme mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase in rat brain [J].
Cullingford, TE ;
Eagles, DA ;
Sato, H .
EPILEPSY RESEARCH, 2002, 49 (02) :99-107